The expression levels of specific cyclins can serve as diagnostic or prognostic biomarkers in cancer. For instance, high levels of Cyclin D1 in breast cancer are often associated with poor prognosis and resistance to certain therapies. Measuring the levels of cyclins can help in stratifying patients and tailoring personalized treatment strategies.
